您当前的位置:

MSCs derived membrane coating nanoparticles targeted delivery itaconic acid to regulate M1 macrophage pyroptosis for osteoarthritis therapy

 

》》文章原文链接:MSCs derived membrane coating nanoparticles targeted delivery itaconic acid to regulate M1 macrophage pyroptosis for osteoarthritis therapy

》》Journal:Appl Mater Today.

》》相关产品:Nigericin sodium salt (SJ-MA0064)Lipopolysaccharides (LPS) (SJ-MB0005)  Itaconic acid (SJ-MX1492)

》》产品引用描述:

                                     

》》Abstract

Osteoarthritis (OA) is a common chronic inflammatory disorder and a major cause of disability. Previous studies have shown that M1 macrophages play an important role in promoting increased inflammation in OA. And because the activated M1 macrophages highly expresses folate receptors, folate (FA) modified nanoparticles provide a new method for targeted drug delivery to macrophages. In this study, we reported itaconic acid (ITA) loaded nanoparticles encapsulated in FA modified cell membranes (FMINPs) as a potential therapeutic agent for OA treatment. This negative charged system has a core-shell structure with a particle size of 162.3 ± 3.65 nm and the system could slowly release ITA within 7 days. The cellular uptake of nanoparticles increased after FA modification. Importantly, the nanoparticles could inhibit the pyroptosis behavior of M1 macrophages by reducing the activity of NLRP3/capase-1/GSDMD protein, thereby alleviating the inhibitory effect of inflammatory microenvironment on mesenchymal stem cells (MSCs) activity and chondrogenic differentiation. Intraarticular injection of nanoparticles protected joint cartilage against OA development and reduced inflammatory response in the OA rat model. All in all, as a potential therapeutic agent, this system can target FA receptor for OA treatment, and the NLRP3/capase-1/GSDMD axis is indicated as an underlying mechanism of destructive cartilage disorders.

》》部分文献数据展示:

Fig. 3:G) Fluorescent images of ROS by using FDCH-FA fluorescence probe. H) Immunofluorescence staining of IL-1β. I) Immunofluorescence imaging of IL-18. J-K) Inflammation related protein detection by ELISA for J) IL-1β and K) IL-18, n = 3. L-M) Inflammation related gene detection by qRT-PCR for J) IL-1βand K) IL-18, n = 3. 

 

上一篇:Eur. J. Med. Chem. 2024 Nov 5; 277:116719. 下一篇:Cells. 2024 August 27; 13(17):1439.